Subjects | 19 |
Male/female | 4/15 |
Age yrs | 42±13 |
Height m | 1.70±0.09 |
Weight kg | 72±14 |
NYHA class II/III | 3/16 |
NT-proBNP pg·mL−1 | 947±1606 |
Haemodynamics | |
P̄pa mmHg | 53±19 |
PVR dyn·s·cm−5 | 845±460 |
Cardiac index L·min−1·m−2 | 2.7±0.9 |
Right atrial pressure mmHg | 7±4 |
P̄pcw mmHg | 5.7±2.4 |
Exercise capacity | |
6-min walk distance m | 496±108 |
Peak work W | 78±42 |
Peak V′O2 mL·kg−1·min−1 | 15±4 |
Peak V′E L·min−1 | 63±30 |
Peak V′E/V′CO2 | 51±13 |
Medication | |
Single/combination treatment | 8/11 |
Treatment duration months | 20±16 |
Data are presented as n or mean±sd. NYHA: New York Heart Association; NT-proBNP: N-terminal pro-B-type natriuretic peptide; P̄pa: mean pulmonary artery pressure; PVR: pulmonary vascular resistance; P̄pcw: pulmonary capillary wedge pressure; V′O2: oxygen uptake; V′E: minute ventilation; V′E/V′CO2: ventilatory equivalent for carbon dioxide.